Jatroman AB

Active
559196-1676Limited company (AB)Registered 2019STOCKHOLM

Key figures

21 275 kr−71,6%
Revenue 2025
−39,4%
Average annual change 2020–2025
0200 k400 k600 k202020212022202320242025

Key figures

2025

Summary: Jatroman AB

What kind of company is it?

Jatroman AB (org. no. 559196-1676) is a limited company (AB). The company was registered in 2019 and has existed for 7 years. Registered seat: Stockholm. Industry according to Statistics Sweden: specialised hospital somatic activities (SNI 86102).

How is the company doing financially?

Net sales in financial year 2025 were 21 275 kr, down 71,6 % on the previous year (74 816 kr). From 2020 to 2025, net sales declined by an average of 39,4 % per year. This is the lowest net sales among the reported years (2020–2025). Net profit for 2025 was 40 123 kr (189 % of net sales). The company was profitable in all 6 reported financial years. Employees in financial year 2025: 1. Net sales per employee were 21 275 kr. At the end of financial year 2025, total assets were 1 022 473 kr and equity 750 160 kr (equity ratio 73,4 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Sales revenue447 282162 820139 50274 81621 275
Profit for the reporting year203 21063 35456 54116 02740 123
Retained earnings of previous periods—————
Total assets898 408946 3391 031 4691 041 7321 022 473
Total liabilities324 293308 870337 459331 695272 313
Total equity574 115637 469694 010710 037750 160
Employees————1

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.